First Choice Neurology

First Choice Neurology Research Center 1 Clinical Trials

First Choice Neurology Research Centers offer clinical trials for Alzheimer’s disease (AD), Dementia, Tonic Clonic Seizures, and other neurological disorders.

Research Center 1 Clinical Trials

Aptinyx Clinical Trial – Patients with Parkinson’s and Memory Complaints

Phase 2 - 4 month clinical trial for patients diagnosed with Parkinson's disease (PD) that also have memory complaints.


Eli Lilly AACM – Patients at Risk for Developing Alzheimer's Disease

a. Patients would be getting Donanemab during the clinical trial
b. Patients have to be asymptomatic - no memory issues
c. Family history of Alzheimer's disease


Biohaven Adult Migraine Clinical Trials

There are two open trials for patients that need both preventive migraine medications and acute migraine medications.


Biohaven Pediatric Migraine Clinical Trials

There are two open trials for children ages 6-17, participants will be getting placebo vs. nurtec.


T3D Therapeutics – Mild – to – Moderate Alzheimer’s Disease

A phase 2 six-month clinical trial for patients with mild-to-moderate Alzheimer’s Disease.


ICARE Clinical Trial

A phase 4 clinical trial and patients will be receiving Aduhelm (aducanumab) newly approved FDA drug to treat Alzheimer’s disease.


Contact First Choice Neurology Research Center 1

The Neurology Group, LLC
9090 SW 87 Court, Suite 200
Miami, FL 33176
Phone: (305) 596-2080
Fax: (305) 351-7905

Providers:
Paul Damski, MD
Allan Herskowitz, MD
Brad Herskowitz, MD
Bernard Gran, MD
Jeffrey Gran PsyD
Alberto Pinzon, MD
Sergio Jaramillo, MD

Contact:
Nicole Baldassini
Clinical Research Coordinator
(305) 596-2080 ext. 1111
nbaldassini@fcneurology.net

Translate »